University of Bologna
Serum factors predict neoangiogenesis in canine lymphoma models
Published in Managed Care Law Weekly, December 4th, 2005
"Canine non-Hodgkin lymphoma (NHL) is considered to be a good animal model for its human counterpart; nevertheless, comparative data on neoangiogenesis are completely lacking," investigators in Italy report.
"The aim of this study is to investigate the levels of serum vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) 2 and 9 in lymphoma-affected dogs," said F. Gentilini and colleagues, University of Bologna.
According to researchers, "circulating levels of VEGF and both MMP 2 and 9 activities significantly correlate with the WHO substage...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
More Articles from Managed Care Law Weekly
- End-Stage Renal Disease
Health plan chosen to participate in dialysis healthcare delivery project - Information Technology
Fidelis Care selects HealthTrio connect to offer online services to providers - King Pharmaceuticals, Inc.
Drug company reports resolution over rebates to Medicaid, other programs - Medicare
AvMed to offer medication therapy management program to seniors - Medicare
Devon Health partners with Humana to offer Medicare Advantage network - Medicare
Drugstore chain offering education initiative for Medicare prescription plan - More from this issue of Managed Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
